U.S. markets closed

Biogen Inc. (BIIB)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
243.78+2.03 (+0.84%)
At close: 1:00PM EST

243.47 -0.31 (-0.13%)
After hours: 3:17PM EST

Show:
Income Statement
Balance Sheet
Cash Flow
Annual
Subscribe to Premium to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Breakdown
ttm
12/31/2019
12/31/2018
12/31/2017
12/31/2016
Total Revenue
14,263,300
14,377,900
13,452,900
12,273,900
11,448,800
Cost of Revenue
1,761,700
1,955,400
1,816,300
1,630,000
1,478,700
Gross Profit
12,501,600
12,422,500
11,636,600
10,643,900
9,970,100
Operating Expense
5,829,300
5,386,800
5,635,800
5,116,100
4,317,000
Operating Income
6,672,300
7,035,700
6,000,800
5,527,800
5,653,100
Net Non Operating Interest Income Expense
-145,300
-67,400
-88,100
-172,300
-196,600
Other Income Expense
-104,000
157,600
-13,100
-226,700
-523,500
Pretax Income
6,423,000
7,125,900
5,899,600
5,128,800
4,933,000
Tax Provision
1,255,100
1,158,000
1,425,600
2,458,700
1,237,300
Earnings from Equity Interest Net of Tax
-25,300
-79,400
0
0
0
Net Income Common Stockholders
5,082,400
5,888,500
4,430,700
2,539,100
3,702,800
Diluted NI Available to Com Stockholders
5,082,400
5,888,500
4,430,700
2,539,100
3,702,800
Basic EPS
-
0.0315
0.0216
0.0119
0.017
Diluted EPS
-
0.0314
0.0216
0.0119
0.0169
Basic Average Shares
-
187,100
204,900
212,600
218,400
Diluted Average Shares
-
187,400
205,300
213,000
218,800
Total Operating Income as Reported
6,658,400
7,042,600
5,888,600
5,344,200
5,150,400
Total Expenses
7,591,000
7,342,200
7,452,100
6,746,100
5,795,700
Net Income from Continuing & Discontinued Operation
5,082,400
5,888,500
4,430,700
2,539,100
3,702,800
Normalized Income
5,137,434
5,717,250
4,432,671
2,667,260
4,082,169
Interest Income
67,200
120,000
112,500
78,500
63,400
Interest Expense
212,500
187,400
200,600
250,800
260,000
Net Interest Income
-145,300
-67,400
-88,100
-172,300
-196,600
EBIT
6,635,500
7,313,300
6,100,200
5,379,600
5,193,000
EBITDA
7,115,300
-
-
-
-
Reconciled Cost of Revenue
1,565,200
1,764,700
1,547,000
1,363,700
1,181,600
Reconciled Depreciation
479,800
680,600
1,016,600
1,081,000
682,700
Net Income from Continuing Operation Net Minority Interest
5,082,400
5,888,500
4,430,700
2,539,100
3,702,800
Total Unusual Items Excluding Goodwill
-68,400
204,600
-2,600
-213,600
-506,500
Total Unusual Items
-68,400
204,600
-2,600
-213,600
-506,500
Normalized EBITDA
7,183,700
7,789,300
7,119,400
6,674,200
6,382,200
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-13,366
33,350
-629.2
-85,440
-127,131